08 August 2022>: Clinical Research
Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity
Beatriz Barranco-Fragoso 12ABC , Shreya C. Pal 34CDEFG , Luis E. Díaz-Orozco 34ABCDEF , Rita Dorantes-Heredia 5BCD , Xingshun Qi 6F , Nahum Méndez-Sánchez 34ACDEF*DOI: 10.12659/MSM.937528
Med Sci Monit 2022; 28:e937528
Figure 4 Increased hepatic dendritic cells (CD11c+, hDCs) expression in liver tissue according to patient’s body mass index (BMI)A graphic/schematic distribution of the liver expression of hDCs (CD11c+) according to patients’ BMI. Hematoxylin and Eosin (H), and Masson trichrome stains in liver biopsy form patients with different BMIs. Liver expression of hDCs (CD11c+) according to patients’ BMI.